Crossmark

Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage

Crossref DOI link: https://doi.org/10.1186/s13195-020-00684-5

Published Online: 2020-09-29

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bousiges, Olivier https://orcid.org/0000-0001-6786-3191
Philippi, Nathalie

Lavaux, Thomas

Perret-Liaudet, Armand

Lachmann, Ingolf

Schaeffer-Agalède, Caroline

Anthony, Pierre

Botzung, Anne

Rauch, Lucie

Jung, Barbara

de Sousa, Paulo Loureiro

Demuynck, Catherine

Martin-Hunyadi, Catherine

Cretin, Benjamin

Blanc, Frédéric
Funding

Funding for this research was provided by:

PHRC interégional
License Information

Text and Data Mining valid from 2020-09-29

Version of Record valid from 2020-09-29
More Information

Article History

Received: 20 March 2020

Accepted: 10 September 2020

First Online: 29 September 2020

Ethics approval and consent to participate

: CPP Est IV, Eudract 2012-A00992-41 / HUS 5330.

: Not applicable

: Ingolf Lachmann provided the ELISA alpha-synuclein kits and reports that he is an employee of AJ Roboscreen GmbH®, Leipzig, Germany.

Document is current

Any future updates will be listed below